May 19: The Week in Cancer News
Cancer drugs are affected by shortages, and angiogenesis inhibitors make a comeback in combination treatments.
Progress Against Cancer
Cancer drugs are affected by shortages, and angiogenesis inhibitors make a comeback in combination treatments.
Men are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
Mammography screening recommendation pushed back to age 40, and pancreatic cancer vaccine shows promising immune response.
An increased risk of early death exists even after treatment for childhood cancer, but survivors also have the potential...
An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
Researchers discover a new way breast density can impact cancer risk, and CAR T-cell therapy remains out of reach...
Although not common, a cancer diagnosis during pregnancy or the onset of a pregnancy while a woman is receiving...
More programs address sexual health in cancer survivors, and survey suggests health insurance often doesn’t cover genetic tumor testing.
People of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment...
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman...